OTOP3 | Otopetrin 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
PCNX | Pecanex homolog (Drosophila) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PCNXL2 | Pecanex-like 2 (Drosophila) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
PCNXL3 | Pecanex-like 3 (Drosophila) | Predicted membrane proteins
| | | | | Expressed in all |
PCNXL4 | Pecanex-like 4 (Drosophila) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PIEZO1 | Piezo-type mechanosensitive ion channel component 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PIEZO2 | Piezo-type mechanosensitive ion channel component 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
PIGB | Phosphatidylinositol glycan anchor biosynthesis, class B | Predicted membrane proteins
| | | | | Mixed |
PIGG | Phosphatidylinositol glycan anchor biosynthesis, class G | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PIGM | Phosphatidylinositol glycan anchor biosynthesis, class M | Disease related genes Predicted membrane proteins
| | | | | Mixed |
PIGN | Phosphatidylinositol glycan anchor biosynthesis, class N | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PIGO | Phosphatidylinositol glycan anchor biosynthesis, class O | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PIGU | Phosphatidylinositol glycan anchor biosynthesis, class U | Predicted membrane proteins
| | | | | Expressed in all |
PIGW | Phosphatidylinositol glycan anchor biosynthesis, class W | Predicted membrane proteins
| | | | | Expressed in all |
PIGZ | Phosphatidylinositol glycan anchor biosynthesis, class Z | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PKD1 | Polycystic kidney disease 1 (autosomal dominant) | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PKD1L1 | Polycystic kidney disease 1 like 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
PKD1L3 | Polycystic kidney disease 1-like 3 | Predicted membrane proteins Transporters
| | | | | Not detected |
PKDREJ | Polycystin (PKD) family receptor for egg jelly | Predicted membrane proteins
| | | | | Tissue enriched |
POMT1 | Protein-O-mannosyltransferase 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
POMT2 | Protein-O-mannosyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
PTCH1 | Patched 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
PTCH2 | Patched 2 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PTCHD1 | Patched domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PTCHD2 | Patched domain containing 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
PTCHD4 | Patched domain containing 4 | Predicted membrane proteins
| | | | | Mixed |
RFT1 | RFT1 homolog (S. cerevisiae) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
RHAG | Rh-associated glycoprotein | CD markers Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Transporters
| | | | | Group enriched |
RHCE | Rh blood group, CcEe antigens | Blood group antigen proteins CD markers Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RHCG | Rh family, C glycoprotein | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RHD | Rh blood group, D antigen | Blood group antigen proteins CD markers Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RNF139 | Ring finger protein 139 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
RNF145 | Ring finger protein 145 | Predicted membrane proteins
| | | | | Expressed in all |
RP11-545J16.1 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000370952} | Predicted membrane proteins
| | | | | Not detected |
SCN10A | Sodium channel, voltage-gated, type X, alpha subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Not detected |
SCN11A | Sodium channel, voltage-gated, type XI, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
SCN1A | Sodium channel, voltage-gated, type I, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SCN3A | Sodium channel, voltage-gated, type III, alpha subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
SCN4A | Sodium channel, voltage-gated, type IV, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
SCN5A | Sodium channel, voltage-gated, type V, alpha subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SCN7A | Sodium channel, voltage-gated, type VII, alpha subunit | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SCN8A | Sodium channel, voltage gated, type VIII, alpha subunit | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SCN9A | Sodium channel, voltage-gated, type IX, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
SERINC1 | Serine incorporator 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SERINC2 | Serine incorporator 2 | Predicted membrane proteins
| | | | | Mixed |
SERINC3 | Serine incorporator 3 | Predicted membrane proteins
| | | | | Expressed in all |
SERINC4 | Serine incorporator 4 | Predicted membrane proteins
| | | | | Tissue enriched |
SERINC5 | Serine incorporator 5 | Predicted membrane proteins
| | | | | Expressed in all |